Free Trial

Quantinno Capital Management LP Purchases 54,628 Shares of Eastman Chemical (NYSE:EMN)

Eastman Chemical logo with Basic Materials background

Quantinno Capital Management LP raised its stake in Eastman Chemical (NYSE:EMN - Free Report) by 126.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 97,951 shares of the basic materials company's stock after purchasing an additional 54,628 shares during the quarter. Quantinno Capital Management LP owned approximately 0.08% of Eastman Chemical worth $8,945,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Mufg Securities Americas Inc. acquired a new position in Eastman Chemical in the 4th quarter valued at $156,000. Nomura Holdings Inc. bought a new stake in shares of Eastman Chemical in the 4th quarter valued at about $349,000. Nuveen Asset Management LLC grew its position in shares of Eastman Chemical by 2.4% in the 4th quarter. Nuveen Asset Management LLC now owns 249,867 shares of the basic materials company's stock valued at $22,818,000 after buying an additional 5,933 shares during the last quarter. Occudo Quantitative Strategies LP bought a new stake in shares of Eastman Chemical during the 4th quarter valued at about $1,444,000. Finally, Millennium Management LLC raised its stake in Eastman Chemical by 6,019.3% during the 4th quarter. Millennium Management LLC now owns 114,676 shares of the basic materials company's stock worth $10,472,000 after buying an additional 112,802 shares during the period. 83.65% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

EMN has been the topic of a number of recent analyst reports. Piper Sandler dropped their price target on Eastman Chemical from $105.00 to $99.00 and set a "neutral" rating on the stock in a report on Monday, April 7th. UBS Group lowered their price target on Eastman Chemical from $123.00 to $115.00 and set a "buy" rating for the company in a research report on Monday, April 7th. Wells Fargo & Company decreased their target price on Eastman Chemical from $125.00 to $90.00 and set an "overweight" rating for the company in a research report on Wednesday, April 9th. KeyCorp dropped their price target on Eastman Chemical from $120.00 to $106.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Finally, StockNews.com downgraded Eastman Chemical from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $99.15.

Check Out Our Latest Analysis on EMN

Eastman Chemical Stock Performance

Shares of NYSE EMN traded down $0.49 during trading hours on Monday, hitting $82.09. 1,412,323 shares of the company's stock were exchanged, compared to its average volume of 1,076,555. Eastman Chemical has a 1-year low of $70.90 and a 1-year high of $114.50. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.51 and a quick ratio of 0.78. The stock has a market capitalization of $9.48 billion, a price-to-earnings ratio of 10.69, a PEG ratio of 1.22 and a beta of 1.29. The company's 50-day moving average price is $81.63 and its 200-day moving average price is $91.82.

Eastman Chemical (NYSE:EMN - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.02. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%. The firm had revenue of $2.29 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the company posted $1.61 earnings per share. The business's revenue for the quarter was down .9% compared to the same quarter last year. On average, sell-side analysts expect that Eastman Chemical will post 8.55 earnings per share for the current fiscal year.

Eastman Chemical Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 8th. Stockholders of record on Friday, June 13th will be issued a dividend of $0.83 per share. This represents a $3.32 annualized dividend and a dividend yield of 4.04%. The ex-dividend date of this dividend is Friday, June 13th. Eastman Chemical's dividend payout ratio (DPR) is presently 42.24%.

Eastman Chemical Company Profile

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Further Reading

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Should You Invest $1,000 in Eastman Chemical Right Now?

Before you consider Eastman Chemical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.

While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines